ImmuPharma PLC New Phase III Lupuzor Trial Data Positive by DirectorsTalk
https://vimeo.com/272518425
ImmuPharma PLC (LON:IMM) Chairman Tim McCarthy talks to DirectorsTalk about the further analysis of the results from its pivotal Phase III trial of Lupuzor and final results. Tim talks us through the key take away highlights from the statement, explains the positive data that has emerged from further analysis, why predictive biomarkers important, updates us on the currently ongoing extension trial and tells us what the next steps are for the company.
Uploaded 2018-05-30T06:55:51.000Z Aerials and Satellites Wakefield
Featured Post By Aerial Services
Man avoids rain puddle by pressing button and summoning his Tesla
To avoid a rather sizable puddle of rainwater, a Reddit user employed a helpful piece of Tesla technology, the "Summon" feature....
/https%3A%2F%2Fblueprint-api-production.s3.amazonaws.com%2Fuploads%2Fcard%2Fimage%2F700775%2F44621cf5-0dc1-49a5-94ee-f3a942397a4c.jpg)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment